In the United States, 9 out of 10 prescriptions filled are for generic drugs. Increasing the availability of generic drugs helps to create competition in the marketplace, which then helps to make treatment more affordable and increases access to healthcare for more patients.
The FDA’s Office of Generic Drugs (OGD) within the Center for Drug Evaluation in Research ensures that people have access to safe, affordable generic drugs by following a rigorous review process that includes:
Many people have questions about whether generic drugs are really as good as the name brand medications and, if so, why there is a cost savings. To help educate patients about FDA’s rigorous review process, the economics of pricing, and related issues, FDA offers a range of educational materials, including videos, graphics, fact sheets, and related resources. The FDA also provides an overview of the basics regarding the generic drug review process, FDA standards and pricing, and answers to frequently asked questions.
Email RobynWoods@creighton.edu to receive a digest of the day’s BHIC posts via email.